moxifloxacin has been researched along with Co-infection in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
| Alexander, E; Das, AF; File, TM; Gelone, SP; Goldberg, L; Heinrich, S; Moran, GJ; Patel, P; Paukner, S; Sandrock, C; Schranz, J; Vidal, JE; Waites, KB | 1 |
| Cao, Y; Xu, S; Zhou, M; Zhu, F | 1 |
| Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS | 1 |
| Aung, E; Bradshaw, CS; Chen, MY; Chow, EPF; Fairley, CK; Garland, SM; Murray, G; Ong, JJ; Read, TRH | 1 |
| Liu, J; Long, X; Luo, H; Pan, X; Shen, F; Wang, S; Wu, J; Yao, L; Yuan, T | 1 |
| Taylor-Robinson, D | 1 |
| Bateson, AL; Butcher, PD; Charalambous, S; Churchyard, GJ; Clouting, HE; Coleman, D; Geldenhuys, H; Harrison, TS; Hatherill, M; Jindani, A; Magweta, L; McHugh, TD; McIlleron, HM; Mitchison, DA; Mungofa, S; Nunn, AJ; Nyirenda, S; Phillips, PP; Shah, NA; Shepherd, J; van Dijk, JH; Zizhou, S; Zvada, SP | 1 |
| Ahuja, SD; Proops, DC; Trieu, L | 1 |
| Adamson, J; Chirehwa, M; Denti, P; Essack, S; Govender, K; Kimba-Phongi, E; McIlleron, H; Naidoo, A; Naidoo, K; Padayatchi, N; Yende-Zuma, N | 1 |
| Eguchi, H; Hotta, F; Ishimaru, M; Kogiso, M; Kusaka, S; Nishimura, K; Shimomura, Y; Yaguchi, T | 1 |
| Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
| Fan, A; Geng, N; Wang, Y; Xue, F; Yue, Y; Zhang, H | 1 |
4 trial(s) available for moxifloxacin and Co-infection
| Article | Year |
|---|---|
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.
Topics: Adult; Bacteria; Coinfection; Community-Acquired Infections; Diterpenes; Humans; Microbial Sensitivity Tests; Moxifloxacin; Pneumonia, Bacterial; Polycyclic Compounds; Thioglycolates | 2022 |
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; HIV Seropositivity; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Young Adult | 2014 |
Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.
Topics: Adult; Africa; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Benzoxazines; Coinfection; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; Fluoroquinolones; HIV Infections; Humans; Male; Moxifloxacin; Reverse Transcriptase Inhibitors; Rifampin; Tuberculosis, Pulmonary | 2017 |
Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Candidiasis, Vulvovaginal; China; Coinfection; Diagnosis, Differential; Drug Administration Schedule; Female; Fluoroquinolones; Follow-Up Studies; Humans; Incidence; Moxifloxacin; Quinolines; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial | 2013 |
9 other study(ies) available for moxifloxacin and Co-infection
| Article | Year |
|---|---|
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |
Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.
Topics: Anti-HIV Agents; Betacoronavirus; China; Clinical Laboratory Techniques; Coinfection; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Mellitus, Type 2; Drug Combinations; gamma-Globulins; HIV; HIV Infections; Humans; Lopinavir; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole | 2020 |
Clinical Characteristics of Anorectal Mycoplasma genitalium Infection and Microbial Cure in Men Who Have Sex With Men.
Topics: Adult; Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Coinfection; Gonorrhea; Homosexuality, Male; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Pristinamycin; Proctitis; Rectal Diseases; Sexual and Gender Minorities; Sexual Behavior; Victoria; Young Adult | 2018 |
Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Coinfection; Female; Fluoroquinolones; Humans; Immunoglobulins; Influenza A Virus, H7N9 Subtype; Influenza, Human; Methylprednisolone; Moxifloxacin; Mycoplasma pneumoniae; Oseltamivir; Pneumonia, Mycoplasma | 2018 |
Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts.
Topics: Anti-Bacterial Agents; Azithromycin; Coinfection; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; HIV Infections; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Urethritis | 2014 |
Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA.
Topics: Antibiotic Prophylaxis; Antitubercular Agents; Coinfection; Fluoroquinolones; Follow-Up Studies; HIV Infections; Humans; Moxifloxacin; Mycobacterium tuberculosis; New York City; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2015 |
A super-infection in the cornea caused by Stemphylium, Acremonium, and α-Streptococcus.
Topics: Acremonium; Aged; Anti-Infective Agents; Cefmenoxime; Coinfection; Cornea; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Moxifloxacin; Saccharomycetales; Streptococcus | 2017 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |